1
Patrick S L Wong, David E Edgren, Liang C Dong, Crystal Pollock Dove: Controlled release liquid active agent formulation dosage forms. Alza Corporation, D Byron Miller, Samuel E Webb, January 29, 2002: US06342249 (60 worldwide citation)

Controlled release of liquid, active agent formulations is provided by dispersing porous particles containing the liquid active agent formulation in osmotic, push-layer dosage forms. The dosage forms may provide for continuous or pulsatile delivery of active agents.


2
Patrick S L Wong, David E Edgren: Gastric retaining oral liquid dosage form. Alza Corporation, Samuel E Webb, October 21, 2003: US06635281 (56 worldwide citation)

The present invention is directed to an active agent dosage form which is adapted for retention in the stomach and useful for the prolonged delivery of a liquid, active agent formulation to a fluid environment of use. The liquid, active agent formulation is sorbed into porous particles that are disp ...


3
Liang Chang Dong, Patrick S L Wong, Atul Devdatt Ayer, Padmaja Shivanand, Michael A DesJardin: Osmotic dosage form composed of an extruded polymer tube form. ALZA Corporation, Samuel E Webb, December 10, 2002: US06491683 (32 worldwide citation)

A dosage form manufactured from an extruded polymer tube and method for manufacturing the dosage form are disclosed. The dosage form is preferably an osmotic dosage form and includes a therapeutic agent and an expandable composition contained within the lumen of the extruded polymer tube.


4
Patrick S L Wong, David E Edgren, Liang C Dong, Crystal Pollock Dove: Controlled release liquid active agent formulation dosage forms. Alza Corporation, Samuel E Webb, July 22, 2003: US06596314 (28 worldwide citation)

Controlled release of liquid, active agent formulations is provided by dispersing porous particles containing the liquid active agent formulation in osmotic, push-layer dosage forms. The dosage forms may provide for continuous or pulsatile delivery of active agents.


5
Patrick S L Wong, Liang Chang Dong, David E Edgren, Felix Theeuwes, Phyllis I Gardner, Francisco Jao, Jason J Wan: Prolonged release active agent dosage form adapted for gastric retention. Alza Corporation, Samuel E Webb, April 15, 2003: US06548083 (27 worldwide citation)

The present invention is directed to an active agent dosage form which is adapted for retention in the stomach and useful for the prolonged delivery of an active agent formulation to a fluid environment of use. The active agent dosage form is a polymer matrix that swells upon contact with the fluids ...


6
Patrick S L Wong, Liang C Dong, Jiansheng Wan: Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings. Alza Corporation, Samuel E Webb, July 16, 2002: US06419952 (25 worldwide citation)

A dosage form comprising a gelatin capsule formed with a composite wall and containing a liquid, active agent formulation where the wall comprises a barrier layer formed over the external surface of the gelatin capsule, an expandable layer formed over the barrier layer and a semipermeable layer form ...


7
Dean Y Li, Kye Won Park: Promoting angiogenesis with netrin1 polypeptides. University of Utah Research Foundation, Stoel Rives, Samuel E Webb, November 25, 2008: US07456151 (20 worldwide citation)

The present invention provides methods and compositions for modulating proliferation, differentiation, migration, and adhesion of cardiovascular cell types.


8
Kevin C DeWhitt: System for recycling plastics. Plas2Fuel Corporation, Stoel Rives, Samuel E Webb, July 20, 2010: US07758729 (19 worldwide citation)

One embodiment of a method of recycling a plastic material includes heating a plastic material in a treatment chamber in incremental steps through a series of graduated temperature set points wherein each graduated temperature set point corresponds to a vaporization temperature of an individual by-p ...


9
Blair Donaldson: Method for visual field testing. BID Instruments, Stoel Rives, Samuel E Webb, Yury M Colton, August 2, 2011: US07988288 (12 worldwide citation)

A method of ocular testing is provided using a testing apparatus having a display (2) and a control means (6, 17) for controlling movement of a cursor (7). The method comprises providing a fixation target (T), detecting when an observer (1) moves the cursor (7) over the fixation target, and once the ...


10
Padmaja Shivanand, Zahedeh Hatamkhany, Barbara F Laidlaw, Atul D Ayer: Phenytoin therapy. Alza Corporation, D Byron Miller, Samuel E Webb, February 12, 2002: US06346270 (12 worldwide citation)

A therapeutic composition, a dosage form and a method are disclosed for administering phenytoin indicated for the management of epilepsy.